Long term clinical toxicity of radiation therapy in prostate cancer patients with Inflammatory Bowel Disease
- 1 January 2017
- journal article
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 22 (1) , 77-82
Abstract
The study's aim was to examine the clinical impact of radiation therapy (RT) on GI toxicity in Inflammatory Bowel Disease (IBD) patients. IBD has long been considered a risk factor for increased bowel toxicity from RT; however, minimal evidence exists on patients with prostate cancer (PC) and IBD. The tumor registry was queried for patients with IBD and PC from the years 1990-2013. A retrospective review was conducted for patients who received RT. Radiation treatment and toxicity data were collected. Average length of follow-up was 12 years (median 9.54, range 0.42-19.9). The majority had well controlled baseline bowel function on medical management. Prior to radiation, 60% of patients (9/15) and 40% (6/15) reported grade 0 (G0) and grade (G1) diarrhea at baseline, respectively. No baseline proctitis existed. Following radiation treatment, 78% (14/18) of patients experienced G0 diarrhea while 22% (4/18) reported G1 diarrhea. No patients suffered from greater than G1 diarrhea. Sixty-six percent (12/18), 17% (3/18) and 17% (3/18) of patients experienced G0, G1, and G2 proctitis, respectively. No patients suffered post-radiation stricture formation, and all patients with G2 proctitis received 3dCRT. Limited published data is available exploring RT for patients with PC and IBD. This analysis offers valuable insight into appropriate counseling for a rare patient subset. Radiation improved late G1 diarrhea rates. Grade 2 proctitis was only encountered in 3dCRT patients. No post-radiation complications occurred. Our findings suggest that IBD patients experience minimal toxicity in the era of IMRT based RT.Keywords
This publication has 25 references indexed in Scilit:
- Toxicity outcome in patients treated with modulated arc radiotherapy for localized prostate cancerReports of Practical Oncology and Radiotherapy, 2014
- Late rectal and bladder toxicity following radiation therapy for prostate cancer: Predictive factors and treatment resultsReports of Practical Oncology and Radiotherapy, 2013
- Toxicity after 125I prostate brachytherapy in patients with inflammatory bowel diseaseBrachytherapy, 2013
- Epidemiology and Natural History of Inflammatory Bowel DiseasesGastroenterology, 2011
- Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09Journal of Clinical Oncology, 2010
- Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-β 1 -induced down-regulation of leukocyte/endothelial cell adhesionInternational Journal of Radiation Biology, 2002
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Quality of Life in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1992
- Early Cervical Cancer Coexistent With Idiopathic Inflammatory Bowel DiseaseSouthern Medical Journal, 1989